Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains

FEBS Letters

Volumn 478, Issue 1-2, 2000, Pages 183-186

  Hay, Trevor J ^a   Meek, David W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Deletion analysis; MDM2; p53; Phosphorylation

Indexed keywords

ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; GENE DELETION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BINDING SITES; CELL LINE; CHYMOTRYPSIN; HUMANS; MICE; MUTATION; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PHOSPHATES; PHOSPHOPEPTIDES; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINS;

EID: 0034726060     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01850-0     Document Type: Article

References (32)

1. Ashcroft M., Vousden K.H. Oncogene. 18:1999;7637-7643.
2. Jimenez G.S., Khan S.H., Stommel J.M., Wahl G.M. Oncogene. 18:1999;7656-7665.
3. Lakin N.D., Jackson S.P. Oncogene. 18:1999;7644-7655.
4. Levine A.J. Cell. 88:1997;323-331.
5. Meek D.W. Oncogene. 18:1999;7666-7675.
6. Prives C., Hall P.A. J. Pathol. 187:1999;112-126.
7. Zhao R., et al. Genes Dev. 14:2000;981-993.
8. Freedman D.A., Wu L., Levine A.J. Cell. Mol. Life Sci. 55:1999;96-107.
9. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. Cell. 69:1992;1237-1245.
10. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., Vogelstein B. Nature. 362:1993;857-860.
11. Honda R., Tanaka H., Yasuda H. FEBS Lett. 420:1997;25-27.
12. Honda R., Yasuda H. EMBO J. 18:1999;22-27.
13. Freedman D.A., Levine A.J. Mol. Cell. Biol. 18:1998;7288-7293.
14. Haupt Y., Maya R., Kazaz A., Oren M. Nature. 387:1997;296-299.
15. Kubbutat M.H.G., Jones S.N., Vousden K.H. Nature. 387:1997;299-303.
16. Roth J., Dobbelstein M., Freedman D.A., Shenk T., Levine A.J. EMBO J. 17:1998;554-564.
17. Wu X., Bayle J.H., Olson D., Levine A.J. Genes Dev. 7:1993;1126-1132.
18. Kubbutat M.H.G., Ludwig R.L., Levine A.J., Vousden K.H. Cell Growth Differ. 10:1999;87-92.
19. Bottger A., Bottger V., Sparks A., Liu W.-L., Howard S.F., Lane D.P. Curr. Biol. 7:1997;860-869.
20. Ashcroft M., Kubbutat M.H.G., Vousden K.H. Mol. Cell. Biol. 19:1999;1751-1758.
21. Blattner C., Tobiasch E., Litfen M., Rahmsdorf H.J., Herrlich P. Oncogene. 18:1999;1723-1732.
22. Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y., Shkedy D. Proc. Natl. Acad. Sci. USA. 96:2000;14973-14977.
23. de Stanchina E., et al. Genes Dev. 12:1998;2434-2442.
24. Henning W., Rohaly G., Kolzau T., Knippschild U., Maacke H., Deppert W. J. Virol. 71:1997;7609-7618.
25. Mayo L.D., Turchi J.J., Berberich S.J. Cancer Res. 57:1997;5013-5016.
26. Gotz C., Kartarius S., Scholtes P., Nastainczyk W., Montenarh M. Eur. J. Biochem. 266:1999;493-501.
27. Guerra B., Gotz C., Wagner P., Montenarh M., Issinger O.-G. Oncogene. 14:1997;2683-2688.
28. Evan G.I., Lewis G.K., Ramsay G., Bishop J.M. Mol. Cell Biol. 5:1985;3610-3616.
29. Meek, D.W. and Milne, D.M. (2000) in: Stress Response: Methods and Protocols (Keyse, S.M., Ed.), Humana Press Inc. (in press).
30. Lohrum M.A., Ashcroft M., Kubbutat M.H., Vousden K.H. Nat. Cell. Biol. 2:2000;179-181.
31. Stott F.J., et al. EMBO J. 17:1998;5001-5014.
32. Boyle W.J., van der Geer P., Hunter T. Methods Enzymol. 201:1991;110-149.